Delivery Order SPE2DR25D3202-SPE2DR26F8E9C
- Not listed
- The Defense Logistics Agency awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $4,787.34 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count) on January 16, 2026, with an ultimate completion date of February 9, 2026. This firm fixed-price delivery order represents a non-competitive award issued without set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for Yonsa 125 mg tablets (120-count supply) with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a ceiling value of $4,787.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by January 21, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $2,393.67. The order is scheduled for ultimate completion by December 26, 2025, and utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of Yonsa 125 mg tablets (120 count) valued at $14,362.02. This competitively awarded, non-set-aside contract has a firm fixed-price structure with an ultimate completion date of February 25, 2026. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $27,256.32 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The award, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for the supply of Yonsa (125 mg tablets, 120-count package) with an ultimate completion date of February 12, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a contract ceiling value of $4,542.74 and a firm fixed price structure. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by July 2, 2025. The contract was...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E9CDelivery Order
The Defense Logistics Agency awarded a $2,393.67 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on February 3, 2026, for the supply of Yonsa 125 mg tablets (120-count units). This is a competitively awarded contract with no set-aside designation, with performance to be completed by February 25, 2026, and work performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through this comprehensive IDC vehicle, which enables the company to supply a broad range of pharmaceutical products, specialty medications, generic and brand-name drugs, vaccines, and medical supplies to support military healthcare programs globally. The contract supports various federal customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Yonsa, a castration-resistant prostate cancer treatment, exemplifies the company's role in supplying essential oncology medications and specialized therapeutic products to federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/2/26 |